Ardent Health Raises FY2026 GAAP EPS Guidance from $0.78-$1.15 to $0.93-$1.18 vs $0.95 Est; Affirms FY2026 Sales Guidance of $6.400B-$6.700B vs $6.463B Est
Benzinga Newsdesk 2 days ago
NewsGuidance
Ardent Health (NYSE:ARDT) raises FY2026 GAAP EPS guidance from $0.78-$1.15 to $0.93-$1.18 vs $0.95 analyst estimate. Affirms FY2026 sales outlook from $6.400 billion-$6.700 billion to $6.400 billion-$6.700 billion vs
Ardent Health (NYSE:ARDT) raises FY2026 GAAP EPS guidance from $0.78-$1.15 to $0.93-$1.18 vs $0.95 analyst estimate. Affirms FY2026 sales outlook from $6.400 billion-$6.700 billion to $6.400 billion-$6.700 billion vs $6.463 billion estimate.